Announcement of Resolutions of the 10th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
202405 Shanghai Pharmaceutical Investor Relations Activity Record Form - v2
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of maxitengtan tablets
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the resignation of a director
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on I040 receiving a clinical trial approval notice
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval of the marketing application for perindopril tert-butylamine
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on holding a performance briefing for the first quarter of 2024
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on metoclopramide hydrochloride injection passing the generic drug consistency evaluation
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of sacubatl valsartan tablets
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of injectable methotrexate
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on I031 receiving a clinical trial approval notice
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval for production of levosimendan injection
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the approval of new specifications for injectable parecoxib sodium
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the progress of drug clinical trials
Shanghai Pharmaceutical Group Co., Ltd. 2024 First Quarter Report
Announcement of Resolutions of the 9th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the proposed issuance of debt financing products
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on the acceptance of the WST03 preparation clinical trial application
20240409 Shanghai Pharmaceutical Investor Relations Activity Record Form - Hong Kong Roadshow
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on rabeprazole sodium enteric tablets passing the generic drug consistency evaluation
No Data